The effects on MuSCs and myogenic differentiation in DM1 and various mouse and cell models of RNA toxicity are clearly different from those seen in mice with MBNL1, MBNL2, or combined MBNL1 loss/MBNL2 deficiency. This evidence concerns the gene MBNL1 and myotonic dystrophy type 1.